<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="with recombinant human hyaluronidase (Hylenex®) in non-human primates [43]. The" exact="Zika" post="DMAb phase I trial is utilizing this co-formulated approach."/>
 <result pre="A and B viruses [36, 37, 97], Ebolavirus [36, 42]," exact="Zika" post="virus [38], CHIKV [121], rabies [15], and HIV [49]."/>
 <result pre="viruses [36, 37, 97], Ebolavirus [36, 42], Zika virus [38]," exact="CHIKV" post="[121], rabies [15], and HIV [49]. Anti-Dengue Virus pDNA-mAbs"/>
 <result pre="Virus pDNA-mAbs Over 2 billion people are at risk for" exact="Zika" post="virus infection [125]. Building on the early studies with"/>
 <result pre="Both anti-Zika virus wt-DMAb and LALA-DMAb protected AG129 mice against" exact="Zika" post="virus challenge and, in addition, protected against Zika-related damage"/>
 <result pre="a sequential administration strategy on days − 10, − 7, and − 4 before challenge with" exact="Zika" post="virus PRVABC59 on day 0. Macaques expressed on average"/>
 <result pre="time of challenge, and four out of five animals controlled" exact="Zika" post="virus infection. This was the first demonstration that a"/>
 <result pre="translation of the DMAb platform for administration in people. This" exact="Zika" post="virus DMAb candidate is now in a human trial"/>
 <result pre="LNP, have been evaluated targeting rabies [15], HIV [49], and" exact="CHIKV" post="[127]. Human anti-rabies immunoglobulin and the rabies vaccine must"/>
 <result pre="et al. delivered an anti-CHIKV DMAb in combination with a" exact="CHIKV" post="DNA vaccine, demonstrating both immediate and persistent protection against"/>
 <result pre="the safety, tolerability, and pharmacokinetic expression of the anti-E protein" exact="Zika" post="virus DMAb (INO-A002) is currently underway (NCT03831503; trial start"/>
 <result pre="delivery of a DNA-encoded monoclonal antibody protects non-human primates against" exact="Zika" post="virusMol Ther201927597498510.1016/j.ymthe.2019.03.00530962164 39.PatelADiGiandomenicoAKellerAESmithTRFParkDHRamosSet al.An engineered bispecific DNA-encoded IgG antibody"/>
 <result pre="plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or" exact="West Nile" post="virus is similar despite differing plasmid backbones or gene-insertsToxicol"/>
 <result pre="plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or" exact="West Nile" post="virus is similar, without integration, despite differing plasmid backbones"/>
 <result pre="Med.2016375151448145610.1056/NEJMoa160433027732819 125.AlanizAJBacigalupoACattanPESpatial quantification of the world population potentially exposed to" exact="Zika" post="virusInt J Epidemiol201746396697510.1093/ije/dyw36628338754 126.SokDBurtonDRRecent progress in broadly neutralizing antibodies"/>
</results>
